July 12, 2021 07:24 AM EDTUpdated 08:04 AM
Coronavirus

Covid-19 roundup: In­otrem loads up on French fund­ing to take sep­tic shock can­di­date to the next stage; Bel­gian woman dies af­ter be­ing in­fect­ed with 2 vari­ants of con­cern

Nicole DeFeudis

Editor

When Roche vet Jean-Jacques Ga­raud helped found French start­up In­otrem, he was at­tract­ed by the com­pa­ny’s im­munother­a­py for sep­tic shock. Now, that can­di­date is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

Post-Hoc: Biose­cure is dead. Long live Biose­cure? 

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

A service from the Financial Times